Study yields positive results for Boston Scientific's S-ICD system

04/2/2014 | MassDevice.com (Boston)

A clinical study found that patients showed 100% and 99.7% treatment rates for spontaneous ventricular tachyarrhythmias and acute ventricular tachyarrhythmias, respectively, 12 months after receiving Boston Scientific's subcutaneous implantable cardioverter defibrillator, or S-ICD system. The findings were based on real-world data from more than 450 patients with abnormal heart rhythms.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN